Experts discuss the challenges of managing atopic dermatitis in real-world clinical practice, highlighting access barriers due to insurance disparities, the need for creative solutions to provide ...

Clinicians in England and Wales may soon have a new option for treating chronic hand eczema (CHE). The National Institute for Health and Care Excellence (NICE) has recommended delgocitinib (Anzupgo, ...

After a 2023 approval from the FDA, Krystal Biotech has collected more than $95 million from its launch of Vyjuvek, the first treatment for the rare skin disease dystrophic epidermolysis bullosa (DEB) ...

Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of Dermatology/National Psoriasis Foundation ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. When we think about the placement of ...

Experts discuss the recent FDA approval of topical JAK inhibitors for children 2 years or older as a promising advancement in pediatric atopic dermatitis treatment, highlighting their efficacy, their ...

Plaque psoriasis is the most prevalent form of the disease. Unsightly skin can cause patients great anguish, raising their frustration with slow or ineffective therapies. This is the approach used by ...

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the University of British Columbia are extending those possibilities to the skin for ...

THIS REPORT, covering a period of eight successive months, presents significant clinical data obtained after the application of bacitracin topical therapy in 83 cases, 75 of which represent a wide ...

Dr. Abud Bakri, a longevity medicine specialist and a member of Enhanced's Medical Commission, said, "GHK-Cu has been studied for decades as a key regulator of skin biology and collagen synthesis.